Earnings Alerts

Humana Inc (HUM) Earnings: Company Maintains FY Adjusted EPS Forecast at $16.00

By September 3, 2024 No Comments
  • Humana maintains its forecast for adjusted EPS (earnings per share) at approximately $16.00.
  • Analysts’ estimate for adjusted EPS is slightly higher at $16.20.
  • Humana continues to forecast its regular EPS at about $12.81.
  • Analysts had estimated the regular EPS to be higher at $14.54.
  • The company has 13 buy ratings, 13 hold ratings, and 1 sell rating from analysts.

Humana Inc on Smartkarma


Analysts on Smartkarma are closely following Humana Inc., with insightful reports by Baptista Research shedding light on the company’s performance and future prospects. In one report titled “Humana Inc.: Enhanced Strategic Management of Benefit Costs and Member Acquisition Tactics! – Major Drivers,” analysts discuss how Humana presented a mixed set of results for the first quarter of 2024. The company reaffirmed its full-year adjusted EPS guidance and increased its membership growth outlook, showcasing operational resilience and strategic expansions.

In another report by Baptista Research titled “Humana Inc.: Impacts on Pharmacy Benefit Managers (PBMs) Resulting From IRA Changes & Other Major Drivers,” Humana’s first quarter results for 2024 were highlighted along with valuable insights from CEO Bruce Broussard and CFO Susan Diamond. The company’s solid start to 2024 and reaffirmed full-year adjusted earnings per share guidance demonstrate confidence in its performance and growth prospects.



A look at Humana Inc Smart Scores

FactorScoreMagnitude
Value3
Dividend2
Growth3
Resilience3
Momentum3
OVERALL SMART SCORE2.8

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

“`html

Humana Inc. is a managed health care company with a solid long-term outlook based on the Smartkarma Smart Scores. With balanced scores across various factors, including Value, Growth, Resilience, and Momentum, Humana Inc. appears to have a promising future ahead. The company’s focus on providing coordinated health care services to a wide range of customers, including employer groups, government-sponsored plans, and individuals, positions it well for sustainable growth and resilience in the healthcare industry.

“`

“`html

Humana Inc.’s Smartkarma Smart Scores suggest a company that is well-positioned for long-term success. While specific numerical values are not provided, a closer look at the scores for Value, Dividend, Growth, Resilience, and Momentum indicates a company with a solid foundation and growth potential in the managed health care sector. Investors may find Humana Inc. an attractive prospect based on these scores and the company’s strong presence in the United States and Puerto Rico, offering a range of health care products and services to its customers.

“`

Summary of the description of the company:
### Humana Inc. is a managed health care company with medical members located in the United States and Puerto Rico. The Company offers coordinated health care through health maintenance organizations, preferred provider organizations, point-of-service plans, and administrative services products. Humana offers its products to employer groups, government-sponsored plans, and individuals. ###


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars